Join
Live feed
·
PRReleasevia Quantisnow
Curanex Pharmaceuticals Inc logo

Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline

ByQuantisnow·Wall Street's wire, on your screen.
CURX· Curanex Pharmaceuticals Inc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CURX (Curanex Pharmaceuticals Inc) and more on Quantisnow.